对 "评估奥希替尼对接受第一代或第二代表皮生长因子受体 TKI 和铂类化疗后全身性疾病（T790M 阴性）进展的表皮生长因子受体突变阳性 NSCLC 患者疗效的 II 期研究（WJOG12819L）"的更正 [Lung Cancer 177 (2023) 44-50]。

{"title":"对 \"评估奥希替尼对接受第一代或第二代表皮生长因子受体 TKI 和铂类化疗后全身性疾病（T790M 阴性）进展的表皮生长因子受体突变阳性 NSCLC 患者疗效的 II 期研究（WJOG12819L）\"的更正 [Lung Cancer 177 (2023) 44-50]。","authors":"Masayuki Takeda , Mototsugu Shimokawa , Atsushi Nakamura , Kaname Nosaki , Yasutaka Watanabe , Terufumi Kato , Daisuke Hayakawa , Hiroshi Tanaka , Toshiaki Takahashi , Masahide Oki , Motoko Tachihara , Daichi Fujimoto , Hidetoshi Hayashi , Kakuhiro Yamaguchi , Shoichiro Yamamoto , Eiji Iwama , Koichi Azuma , Kazuo Hasegawa , Nobuyuki Yamamoto , Kazuhiko Nakagawa","doi":"10.1016/j.lungcan.2024.107852","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"193 ","pages":"Article 107852"},"PeriodicalIF":4.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0169500224003866/pdfft?md5=c09258544ed0a314ddfbf02e05fc17c8&pid=1-s2.0-S0169500224003866-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation–positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKI and platinum-based chemotherapy” [Lung Cancer 177 (2023) 44–50]\",\"authors\":\"Masayuki Takeda , Mototsugu Shimokawa , Atsushi Nakamura , Kaname Nosaki , Yasutaka Watanabe , Terufumi Kato , Daisuke Hayakawa , Hiroshi Tanaka , Toshiaki Takahashi , Masahide Oki , Motoko Tachihara , Daichi Fujimoto , Hidetoshi Hayashi , Kakuhiro Yamaguchi , Shoichiro Yamamoto , Eiji Iwama , Koichi Azuma , Kazuo Hasegawa , Nobuyuki Yamamoto , Kazuhiko Nakagawa\",\"doi\":\"10.1016/j.lungcan.2024.107852\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18129,\"journal\":{\"name\":\"Lung Cancer\",\"volume\":\"193 \",\"pages\":\"Article 107852\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0169500224003866/pdfft?md5=c09258544ed0a314ddfbf02e05fc17c8&pid=1-s2.0-S0169500224003866-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0169500224003866\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500224003866","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}